| Primary |
| Product Used For Unknown Indication |
24.8% |
| Drug Use For Unknown Indication |
21.0% |
| Nausea |
17.2% |
| Vomiting |
8.3% |
| Pain |
7.6% |
| Tumour Pain |
3.2% |
| Migraine |
2.5% |
| Hypersensitivity |
1.9% |
| Anxiety |
1.3% |
| Asthma |
1.3% |
| Back Pain |
1.3% |
| Bipolar Disorder |
1.3% |
| Breast Cancer |
1.3% |
| Medication Dilution |
1.3% |
| Multiple Sclerosis |
1.3% |
| Pneumonia |
1.3% |
| Sedation |
1.3% |
| Abdominal Discomfort |
0.6% |
| Blood Glucose |
0.6% |
| Dehydration |
0.6% |
|
| Completed Suicide |
13.3% |
| Death |
8.9% |
| Thrombosis |
8.9% |
| Pain |
6.7% |
| Respiratory Arrest |
6.7% |
| Respiratory Rate Decreased |
6.7% |
| Deep Vein Thrombosis |
4.4% |
| Dystonia |
4.4% |
| Mental Status Changes |
4.4% |
| Movement Disorder |
4.4% |
| Respiratory Tract Irritation |
4.4% |
| Restlessness |
4.4% |
| Tremor |
4.4% |
| Vomiting |
4.4% |
| Ammonia Increased |
2.2% |
| Blood Pressure Decreased |
2.2% |
| Cardio-respiratory Arrest |
2.2% |
| Complex Regional Pain Syndrome |
2.2% |
| Depressed Level Of Consciousness |
2.2% |
| Dry Gangrene |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
30.6% |
| Drug Use For Unknown Indication |
14.6% |
| Nausea |
11.1% |
| Pain |
8.6% |
| Foetal Exposure During Pregnancy |
4.9% |
| Vomiting |
4.2% |
| Migraine |
3.2% |
| Convulsion |
2.5% |
| Depression |
2.2% |
| Back Pain |
2.0% |
| Central Nervous System Lymphoma |
2.0% |
| Psoriasis |
2.0% |
| Hypertension |
1.8% |
| Vertigo |
1.8% |
| Blood Glucose |
1.7% |
| Diabetes Mellitus |
1.5% |
| Drug Exposure During Pregnancy |
1.5% |
| Hepatitis C |
1.3% |
| Anxiety |
1.2% |
| Crohn's Disease |
1.2% |
|
| Staphylococcal Bacteraemia |
14.3% |
| Vomiting |
10.0% |
| Drug Hypersensitivity |
8.6% |
| Somnolence |
8.6% |
| Pyrexia |
7.1% |
| Respiratory Arrest |
5.7% |
| Nausea |
4.3% |
| Overdose |
4.3% |
| Respiratory Rate Decreased |
4.3% |
| Type 2 Diabetes Mellitus |
4.3% |
| Cleft Palate |
2.9% |
| Depression |
2.9% |
| Drug Ineffective |
2.9% |
| Gastric Ulcer |
2.9% |
| Injection Site Pain |
2.9% |
| Pain |
2.9% |
| Polycystic Ovaries |
2.9% |
| Premature Baby |
2.9% |
| Respiratory Depression |
2.9% |
| Tinel's Sign |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
25.5% |
| Product Used For Unknown Indication |
18.3% |
| Nausea |
9.6% |
| Pain |
9.4% |
| Depression |
4.1% |
| Anxiety |
3.8% |
| Crohn's Disease |
3.3% |
| Hypertension |
3.2% |
| Vomiting |
2.6% |
| Contraception |
2.5% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Migraine |
2.2% |
| Insomnia |
2.0% |
| Asthma |
1.8% |
| Hepatitis C |
1.8% |
| Non-small Cell Lung Cancer |
1.7% |
| Prophylaxis |
1.5% |
| Sleep Disorder |
1.5% |
| Constipation |
1.4% |
| Headache |
1.4% |
|
| Vomiting |
22.4% |
| Weight Decreased |
7.1% |
| Pain |
6.3% |
| Nausea |
6.0% |
| Weight Increased |
5.4% |
| Ventricular Septal Defect |
5.3% |
| Pyrexia |
5.1% |
| Cholecystitis Chronic |
4.7% |
| Pulmonary Embolism |
4.1% |
| Urinary Tract Infection |
4.1% |
| Wrong Technique In Drug Usage Process |
3.7% |
| Pneumonia |
3.6% |
| Renal Failure Acute |
3.5% |
| White Blood Cell Count Decreased |
3.1% |
| Thrombocytopenia |
3.0% |
| Cholelithiasis |
2.9% |
| Injury |
2.5% |
| White Blood Cell Count Increased |
2.5% |
| Death |
2.4% |
| Deep Vein Thrombosis |
2.4% |
|
| Interacting |
| Grand Mal Convulsion |
32.7% |
| Drug Use For Unknown Indication |
25.5% |
| Hypothyroidism |
10.9% |
| Nausea |
10.9% |
| Urinary Tract Infection |
10.9% |
| Convulsion |
7.3% |
| Insomnia |
1.8% |
|
| Drug Interaction |
22.2% |
| Nausea |
22.2% |
| Toxicity To Various Agents |
22.2% |
| Osteomyelitis |
11.1% |
| Sleep-related Eating Disorder |
11.1% |
| Somnambulism |
11.1% |
|
